Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 38

Sort by

Sort Order Select

Journal Articles

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

Blood (2018) 131 (2): 174–181.

https://doi.org/10.1182/blood-2017-07-793984

Published: 2018

Includes: Supplemental data

Journal Articles

Efficacy of Orally VP16 Plus Prednisone with or without Cyclophosphamide for Refractory and Relapsed Peripheral T-Cell Lymphoma: A Retrospective Single Center Experience

Anne-Blandine Boutin, MD, Marjan Ertault de la Bretonnière, MD, Helene Monjanel, MD, Marlene Ochmann, MD, Hélène Doyen, MD, Philippe Colombat, MD PhD, Emmanuel Gyan, MD PhD

Blood (2014) 124 (21): 6020.

https://doi.org/10.1182/blood.V124.21.6020.6020

Published: 2014

Journal Articles

Relationship Between Metabolic Tumor Volume and Rituximab Pharmacokinetic Parameters in Non-Hodgkin’s Lymphoma

Helene Monjanel, MD, David Ternant, MD PhD, Yann Venel, MD, Caroline Prunier-Aesch, MD PhD, Jean-François Tournamille, MD, Flavie Arbion, MD, Philippe Colombat, MD PhD, Gilles Paintaud, MD PhD, Emmanuel Gyan, MD PhD

Blood (2014) 124 (21): 3644.

https://doi.org/10.1182/blood.V124.21.3644.3644

Published: 2014

Journal Articles

Circulating t(14;18)+ Cells As Predictive Markers Of Follicular Lymphoma Development

Sandrine Roulland, Pharm.D., Ph.D., Ester Morgado, Rachel Kelly, Jocelyne Stephanie Sungalee, Philippe Colombat, MD, PhD, Philippe Solal-Celigny, MD, Gilles Andre Salles, MD, PhD, Paolo Vineis, Bertrand Nadel, PhD

Blood (2013) 122 (21): 364.

https://doi.org/10.1182/blood.V122.21.364.364

Published: 2013

Journal Articles

Concomitant Radiochemotherapy In The Treatment Of Refractory Or Locally Relapsed Diffuse Large B-Cell Lymphoma: A Single Center Retrospective Study

Emmanuel Gyan, MD, PhD, Alban Villate, Severine Lissandre, MD, Lotfi Benboubker, MD, Martine Delain, MD, Philippe Colombat, MD

Blood (2013) 122 (21): 5114.

https://doi.org/10.1182/blood.V122.21.5114.5114

Published: 2013

Journal Articles

Interferon-Alpha With Or Without Rituximab Achieves a High Response Rate and Durable Responses In Relapsed FL: 17 years’ Experience In a Single Centre

Sinziana Radesi-Sarghi, Flavie Arbion, Caroline Dartigeas, MD, Martine Delain, MD, Lotfi Benboubker, MD, Olivier Herault, MD, PhD, Philippe Colombat, MD, Emmanuel Gyan, MD, PhD

Blood (2013) 122 (21): 5126.

https://doi.org/10.1182/blood.V122.21.5126.5126

Published: 2013

Journal Articles

Safety and Efficacy of Abbreviated Induction with Oral Fludarabine (F) and Cyclophosphamide (C) Combined with Dose-Dense IV Rituximab (R) in Previously Untreated Patients with Chronic Lymphocytic Leukemia (CLL) Aged > 65 years : Results of a Multicenter Trial (LLC 2007 SA) On Behalf of the French Goelams/Fcgcll-WM Intergroup

Blood (2012) 120 (21): 434.

https://doi.org/10.1182/blood.V120.21.434.434

Published: 2012

Journal Articles

Immunogenicity and Safety of One Dose of Influenza A H1N1v 2009 Adjuvanted Vaccine for Unpreviously Treated Patients with Binet-Stage A Chronic Lymphoid Leukaemia of B-Cell Type (B-CLL): Result of a Prospective Study Conducted In 9 French Centers by the Intergroupe Français GOELAMS/GFLLC-MW

Jean-Francois Rossi, MD, PhD, Bastien Caumes, Florence Cymbalista, MD, PhD, Odile Launay, MD, Anne Krivine, MD, PHD, Vincent Levy, MD, PhD, Pierre Feugier, MD, PhD, Stéphane Leprêtre, MD, Loic Ysebaert, MD, PhD, Caroline Dartigeas, MD, Philippe Colombat, MD, Didier Bouscary, MD, PhD, Tarik Kanouni, MD, Edouard Tuaillon, MD, PhD, Véronique Leblond

Blood (2010) 116 (21): 3600.

https://doi.org/10.1182/blood.V116.21.3600.3600

Published: 2010

Journal Articles

Phase I/II Study of Escalating Doses of Idarubicin in Combination with Methotrexate, Vindesine and Prednisolone in Patients with Primary Central Nervous System Lymphoma: Results of the GOELAMS LCP99 Multicenter Trial.

Gaelle Olivier, MD, Martine Gardembas, MD, Vincent Delwail, MD, Annie Le Mevel, MD, Martine Escoffre-Barbe, MD, Annie Brion, MD, Jean Michel Boulet, MD, Philippe Solal-Celigny, MD, Pierre Ingrand, MD, Philippe Colombat, MD, PhD

Blood (2009) 114 (22): 2694.

https://doi.org/10.1182/blood.V114.22.2694.2694

Published: 2009

Journal Articles

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Blood (2009) 113 (5): 995–1001.

https://doi.org/10.1182/blood-2008-05-160200

Published: 2009

Journal Articles

Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features

Gandhi Damaj, MD, Marc Bernard, MD, Steven Legouill, MD, Guillaume Cartron, MD, PhD, Annie Le Mevel, MD, Céline Dubus, Christian Berthou, MD, PhD, Philippe Colombat, MD, PhD, Noel Milpied, MD, PhD, Jean Pierre Marolleau, MD, PhD, Thierry Lamy, MD, PhD

Blood (2008) 112 (11): 2603.

https://doi.org/10.1182/blood.V112.11.2603.2603

Published: 2008

Journal Articles

Long Term Molecular Remissions after Autologous Haematopoietic Stem Cell Transplant in Follicular Lymphoma.

Séverine Lissandre, MD, Patrick Vourch, MD, Isabelle Desbois, MD, Lotfi Benboubker, MD, Caroline Dartigeas, MD, Martine Delain, MD, Delphine Senecal, MD, Philippe Colombat, MD, PhD, Emmanuel Gyan, MD

Blood (2008) 112 (11): 2185.

https://doi.org/10.1182/blood.V112.11.2185.2185

Published: 2008

Journal Articles

Successful Treatment of Primary Refractory Bulky Diffuse Large B-Cell Lymphomas with Concomitant Radio-Chemotherapy Followed by Autologous Stem Cell Transplantation : A Single Center Experience

Marie-Anne Couturier, Elise Champeaux-Orange, Delphine Senecal, MD, S.éverine Lissandre, MD, Lotfi Benboubker, MD, Isabelle Barillot, MD, PhD, Gilles Calais, MD, PhD, Philippe Colombat, MD, PhD, Emmanuel Gyan, MD

Blood (2008) 112 (11): 4964.

https://doi.org/10.1182/blood.V112.11.4964.4964

Published: 2008

Journal Articles

High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation (auto-SCT) Versus CHOP Regimen in Patients with Untreated Aggressive Non-Hodgkin’s Lymphoma: An Update of the GOELAMS 072 Trial with a Median Follow-up of 9.8 Years

Thomas Gastinne, Gandhi Damaj, Thierry Lamy, PhD, Norbert Ifrah, Eric Deconinck, Remy Gressin, MD, Philippe Colombat, MD, PhD, Vincent Delwail, Christian Berthou, Jean François Rossi, Jean Luc Harousseau, Noel-Jean Milpied, PhD

Blood (2008) 112 (11): 770.

https://doi.org/10.1182/blood.V112.11.770.770

Published: 2008

Journal Articles

Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.

Michal Sieniawski, MD, Andreas Josting, MD, Carmen Canals, MD, Anthony H. Goldstone, MD, Martin Gramatzki, MD, Didier Blaise, MD, Christian Gisselbrecht, MD, Charles Crawley, MD, Philippe Colombat, MD, Jean-Luc Harousseau, MD, Peter Johnson, MD, Angelo Michele Carella, MD, Anna Sureda, MD, Gerard Socie, MD, Norbert Schmitz, MD

Blood (2007) 110 (11): 834.

https://doi.org/10.1182/blood.V110.11.834.834

Published: 2007

Journal Articles

The Extramedullar Dissemination of Acute Myeloid Leukemic Cells Depends on CD31 (PECAM-1) and CD38 Coexpression Level.

Olivier Herault, MD, PhD, Nathalie Gallay, PhD, Jorge Domenech, MD PhD, Philippe Colombat, MD, Christian Binet, MD

Blood (2006) 108 (11): 1896.

https://doi.org/10.1182/blood.V108.11.1896.1896

Published: 2006

Journal Articles

First Line Treatment with the R-VAD+C Regimen Followed by ASCT for Patients under 65 with a Mantle Cell Lymphoma (MCL). From the GOELAMS Group.

Blood (2006) 108 (11): 4694.

https://doi.org/10.1182/blood.V108.11.4694.4694

Published: 2006

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation Cures CLL: A Retrospective Analysis from the SFGM-TC Registry.

Mauricette Michallet, MD, PhD, Quoc-Hung Lê, MD, Jean-Paul Vernant, MD, PhD, Franck E. Nicolini, MD, PhD, Jean-Luc Harousseau, MD, PhD, Philippe Colombat, MD, PhD, Eric Deconninck, MD, PhD, Bruno Cazin, MD, Didier Blaise, MD, PhD

Blood (2006) 108 (11): 2991.

https://doi.org/10.1182/blood.V108.11.2991.2991

Published: 2006

Journal Articles

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

Blood (2006) 108 (11): 486.

https://doi.org/10.1182/blood.V108.11.486.486

Published: 2006

Journal Articles

GMCLI, Goelams Mantle Cell Lymphoma Index, a New Prognostic Index of Survival for MCL Patients Treated with VAD-C and Autologous PBSCT.

Blood (2006) 108 (11): 2447.

https://doi.org/10.1182/blood.V108.11.2447.2447

Published: 2006

NARROW

R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma

Efficacy of Orally VP16 Plus Prednisone with or without Cyclophosphamide for Refractory and Relapsed Peripheral T-Cell Lymphoma: A Retrospective Single Center Experience

Relationship Between Metabolic Tumor Volume and Rituximab Pharmacokinetic Parameters in Non-Hodgkin’s Lymphoma

Circulating t(14;18)+ Cells As Predictive Markers Of Follicular Lymphoma Development

Concomitant Radiochemotherapy In The Treatment Of Refractory Or Locally Relapsed Diffuse Large B-Cell Lymphoma: A Single Center Retrospective Study

Interferon-Alpha With Or Without Rituximab Achieves a High Response Rate and Durable Responses In Relapsed FL: 17 years’ Experience In a Single Centre

Immunogenicity and Safety of One Dose of Influenza A H1N1v 2009 Adjuvanted Vaccine for Unpreviously Treated Patients with Binet-Stage A Chronic Lymphoid Leukaemia of B-Cell Type (B-CLL): Result of a Prospective Study Conducted In 9 French Centers by the Intergroupe Français GOELAMS/GFLLC-MW

Phase I/II Study of Escalating Doses of Idarubicin in Combination with Methotrexate, Vindesine and Prednisolone in Patients with Primary Central Nervous System Lymphoma: Results of the GOELAMS LCP99 Multicenter Trial.

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Late Relapse of Localized High-Grade Non-Hodgkin’s Lymphoma: Clinical and Biological Features

Long Term Molecular Remissions after Autologous Haematopoietic Stem Cell Transplant in Follicular Lymphoma.

Successful Treatment of Primary Refractory Bulky Diffuse Large B-Cell Lymphomas with Concomitant Radio-Chemotherapy Followed by Autologous Stem Cell Transplantation : A Single Center Experience

High-Dose Chemotherapy Followed by Autologous Stem Cell Transplantation (auto-SCT) Versus CHOP Regimen in Patients with Untreated Aggressive Non-Hodgkin’s Lymphoma: An Update of the GOELAMS 072 Trial with a Median Follow-up of 9.8 Years

Late Events in Patients with Relapsed or Refractory Hodgkin’s Lymphoma Treated with an Autologous Stem Cell Transplantation.

The Extramedullar Dissemination of Acute Myeloid Leukemic Cells Depends on CD31 (PECAM-1) and CD38 Coexpression Level.

First Line Treatment with the R-VAD+C Regimen Followed by ASCT for Patients under 65 with a Mantle Cell Lymphoma (MCL). From the GOELAMS Group.

Allogeneic Hematopoietic Stem Cell Transplantation Cures CLL: A Retrospective Analysis from the SFGM-TC Registry.

Single Treatment with Rituximab Monotherapy for Low-Tumor Burden Follicular Lymphoma (FL): Survival Analyses with Extended Follow-Up (F/Up) of 7 Years.

GMCLI, Goelams Mantle Cell Lymphoma Index, a New Prognostic Index of Survival for MCL Patients Treated with VAD-C and Autologous PBSCT.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only